Is There a Link Between Inflammation and Endocrinopathies in Turner Syndrome?

• Sponsor: Central Hospital, Nancy, France (Other)
• Overall Status: Recruiting
• CT.gov ID: NCT05473091
• Collaborator: (none)
• Enrollment: 180
• Location: 1
• Anticipated Duration (Months): 9.4
• Patients Per Site Per Month: 19.2

Study Details

Study Description

Brief Summary

Liver abnormalities are common in Turner syndrome. The physiopathology of these abnormalities is unknown for the moment but their potentially serious evolution requires additional explorations.

Condition or Disease	Intervention/Treatment	Phase
Turner Syndrome	Other: no intervention

Study Design

• Study Type: Observational
• Anticipated Enrollment: 180 participants
• Observational Model: Case-Control
• Time Perspective: Retrospective
• Official Title: Is There a Link Between Inflammation and Endocrinopathies in Turner Syndrome?
• Actual Study Start Date: Mar 22, 2022
• Anticipated Primary Completion Date: Dec 1, 2022
• Anticipated Study Completion Date: Jan 1, 2023

Arms and Interventions

Arm	Intervention/Treatment
Experimental group	Other: no intervention; retrospective analysis
Control group	Other: no intervention; retrospective analysis

Outcome Measures

Primary Outcome Measures

1. pro inflammatory score [18 years]

Eligibility Criteria

Criteria

• Ages Eligible for Study: 18 Years to 56 Years
• Sexes Eligible for Study: Female

Inclusion Criteria Experimental group:

• Turner syndrome

Inclusion Criteria Control group:

• healthy subjects

Contacts and Locations

Locations

	Site	City	State	Country	Postal Code
1	CHUR de Nancy	Nancy		France

Sponsors and Collaborators

• Central Hospital, Nancy, France

Investigators

None specified.

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.

• Responsible Party: EVA FEIGERLOVA, Dr, Central Hospital, Nancy, France
• ClinicalTrials.gov Identifier: NCT05473091
• Other Study ID Numbers: 2021pi189
• First Posted: Jul 25, 2022
• Last Update Posted: Jul 25, 2022
• Last Verified: Jul 1, 2022

• Studies a U.S. FDA-regulated Drug Product: No
• Studies a U.S. FDA-regulated Device Product: No
• Additional relevant MeSH terms: Turner Syndrome; Gonadal Dysgenesis; Syndrome; Inflammation

Study Results

No Results Posted as of Jul 25, 2022